|
A major goal of research in our laboratory is to understand, at a molecular level, how synthesis of eukaryotic messenger RNA by the multisubunit enzyme RNA polymerase II is regulated. In early work, our laboratory contributed to the identification, purification, and characterization of the mechanisms of action of the set of RNA polymerase II general initiation factors TFIIB, TFIID, TFIIE, TFIIF, and TFIIH, which are essential for transcription initiation by RNA polymerase II at most genes. In subsequent work, our laboratory has exploited this “minimal” enzyme system to investigate the mechanisms governing RNA polymerase II transcription. These efforts have led to the discovery of a collection of transcriptional regulatory proteins with roles in transcription initiation, elongation, and chromatin remodeling. In addition, an unanticipated outgrowth of these studies was the identification of a new family of E3 ubiquitin ligases, including the von Hippel-Lindau tumor suppressor complex as the founding member of this family. As discussed in more detail below, current research in our laboratory is focused on aspects of the mechanism and regulation of RNA polymerase II transcription, as well as investigations of the von Hippel-Lindau tumor suppressor complex and related ubiquitin ligases.
Mechanism and Regulation of Transcription by RNA Polymerase II
The Mediator
The Mediator is a multisubunit transcription factor that performs a critical roles in both transcriptional activation and repression by promoting essential communication between DNA bound transcription factors and RNA polymerase II and the general initiation factors at the promoter. The Mediator was first identified in yeast and found to be composed of more than 20 distinct polypeptides. Our studies have focused on the Mediator complex from mammalian cells. In collaboration with Drs. Michael Washburn and Laurence Florens at the Stowers Institute, we have exploited a MudPIT-based proteomics approach to identify a collection of new mammalian Mediator subunits and to define a set of roughly 30 consensus mammalian Mediator subunits. These studies revealed that, although the overall architecture of the Mediator complex is strikingly conserved throughout evolution from yeast to man, the mammalian Mediator includes a set of additional, metazoan-specific subunits including an alternative form of the Cdk8/Cyclin C/Med12/Med13 kinase module consisting of a previously uncharacterized Cdk8-like kinase and paralogs of Med12 and Med13. Having in hand an apparently complete set of mammalian Mediator subunits is now allowing a more systematic investigation of the functions of individual Mediator subunits in vitro and in cells, with particular emphasis on the metazoan-specific Mediator proteins.
A Family of Related Mammalian Chromatin Remodeling Enzymes
In a line of investigation that began with our characterization of the mammalian TRRAP/Tip60 HAT complex, we identified and are now characterizing two new chromatin remodeling complexes, which we refer to as the SRCAP and Ino80-like complexes. These mammalian chromatin remodelers share some structural and functional similarities with the yeast SWR1 and Ino80 chromatin remodeling complexes. The TRRAP/Tip60, SRCAP, and Ino80-like complexes share a subset of subunits including the actin-related protein Arp4 and the Ruvb-like AAA+ ATPases Tip49a and Tip49b. The SRCAP complex includes the SNF2-related SRCAP ATPase, which was originally identified as a coactivator of CREB and some steroid receptors. Like the yeast SWR1 chromatin remodeling complex, the mammalian SRCAP complex catalyzes exchange of histone H2AZ/H2B dimers into nucleosomes. The Ino80-like complex includes a previously uncharacterized SNF2-related ATPase that resembles yeast Ino80. Like the yeast Ino80 chromatin remodeling complex, the mammalian Ino80-like complex is capable of catalyzing nucleosome sliding. Although the mammalian Ino80-like complex exhibits some similiarities in subunit composition with the yeast Ino80 complex, the Ino80-like complex includes a collection of subunits that appear to be metazoan-specific. Ongoing efforts in our laboratory are aimed at understanding the mechanisms of action of these mammalian chromatin remodeling complexes in vitro and in cells, with particular emphasis on the roles their metazoan-specific subunits play in cellular functions.
RNA Polymerase II Elongation Factors Elongin and ELL
In the past, we have exploited the minimal transcription system composed of RNA polymerase II and the general initiation factors as an assay to identify and purify additional factors that promote transcription elongation. These efforts led to the discovery of two such factors, Elongin and ELL, which both function to increase the overall rate of transcription elongation by RNA polymerase II by suppressing transient pausing by the enzyme at many sites along the DNA.
Elongin is a 3-subunit complex composed of A, B, and C subunits of ~770, 118, and 112 amino acids. In initial studies, cloning of the genes encoding the Elongin subunits and reconstitution and characterization of the recombinant Elongin ABC complex revealed (i) that Elongin A is the transcriptionally active subunit of the Elongin complex and (ii) Elongins B and C form an isolable subcomplex that binds to an ~12 amino acid BC-box present in Elongin A and induces its transcriptional activity. Ongoing studies are aimed at understanding in greater detail the mechanism of Elongin action of regulation of RNA polymerase II activity in vitro and in cells.
The human ELL gene was originally identified as a gene that undergoes frequent translocations with the MLL gene on chromosome 11q23 in a variety of leukemias. Two additional ELL family members, ELL2 and ELL3, have been identified and shown to function similarly to ELL to activate the rate of transcription elongation by RNA polymerase II. ELL family members function in cells as components of multiprotein complexes that include one of the related EAF1 or EAF2 proteins, which we recently showed are potent activators of ELL transcriptional activity. Ongoing studies are aimed at characterizing additional components of these ELL-containing complexes and understanding how ELL and its associated proteins promote RNA polymerase II transcription in vitro and in cells.
Investigations of the VHL Tumor Suppressor Complex and Related E3 Ubiquitin Ligases
In previous work, our laboratory contributed to the discovery that the von Hippel-Lindau (VHL) tumor suppressor protein is an integral component of an E3 ubiquitin ligase that negatively regulates expression of hypoxia-inducible genes by targeting hypoxia-inducible transcription factors ( HIFs ) for ubiquitination and degradation by the proteasome . The VHL gene on chromosome 3p25.5 is mutated in the majority of sporadic clear cell renal carcinomas and in VHL disease, an autosomal dominant familial cancer syndrome that predisposes affected individuals to a variety of tumors, including clear cell carcinoma, cerebellar hemangioblastomas and hemangiomas , retinal angiomas , and pheochromocytomas . These studies demonstrated that, like Elongin A, the VHL protein is a BC-box protein. Purification of the endogenous VHL tumor suppressor complex from rat liver in our laboratory led to the discovery that it is composed of VHL, Elongins B and C, Cullin family member Cul2, and a novel RING finger protein designated Rbx1 and, further, that it possesses intrinsic ubiquitin ligase activity driven by the Rbx1 RING finger. Subsequent studies in our laboratory and elsewhere have led to the identification of additional BC-box proteins (including the Suppressor of Cytokine Signaling (SOCS) proteins) and demonstrated that many are components of a larger family of Elongin BC- and Cul2/Cul5-containing ubiquitin ligases that include Elongins BC and Rbx1 or the related Rbx2 protein. In addition to our ongoing investigations of the mechanism of action of the VHL ubiquitin ligase complex in regulation of hypoxia-inducible transcription, we are currently attempting to develop MudPIT -based proteomics approaches to identify and characterize additional members of the family Elongin BC- and Cul2/Cul5-containing ubiquitin ligases and to identify their associated proteins and substrates.
Academic Appointments: Professor, Department of Biochemistry & Molecular Biology, The University of Kansas School of Medicine
Selected publications
Takahashi H, Martin-Brown S, Washburn MP, Florens L, Conaway JW, Conaway RC. Proteomics
Reveals a Physical and Functional Link between Hepatocyte Nuclear Factor
4α and TFIID [published ahead of print October 5 2009]. J Biol Chem.
2009. doi:10.1074/jbcM109.017954.
Gottschalk AJ, Timinszky G, Kong SE, Jin J, Cai Y, Swanson SK, Washburn MP,
Florens L, Ladurner AG, Conaway JW,
Conaway RC. Poly(ADP-ribosyl)ation directs recruitment and activation of an
ATP-dependent chromatin remodeler. Proc Natl Acad Sci U S A. 2009;106:13770-13774.
Abstract
Conaway RC, Conaway JW.
Mediator comes out from the shadows. Structure. 2009;17:485-486. Abstract
Ding N, Tomomori-Sato C, Sato S, Conaway RC, Conaway JW, Boyer TG. MED19 and MED26 are synergistic
functional targets of the RE1 silencing transcription factor in epigenetic
silencing of neuronal gene expression. J Biol Chem. 2009;284:2648-2656.
Abstract
Yasukawa T, Kamura T, Kitajima S, Conaway RC, Conaway JW, Aso T. Mammalian Elongin A complex mediates
DNA-damage-induced ubiquitylation and degradation of Rpb1. EMBO J. 2008;27:3256-3266.
Abstract
Conaway RC, Conaway JW.
The INO80 chromatin remodeling complex in transcription, replication and repair.
Trends Biochem Sci. 2009;34:71-77. Abstract
Yao T, Song L, Jin J, Cai Y, Takahashi H, Swanson SK,
Washburn MP, Florens L, Conaway RC, Cohen
RE, Conaway JW. Distinct modes of
regulation of the Uch37 deubiquitinating enzyme in the proteasome and in the
Ino80 chromatin-remodeling complex. Mol Cell. 2008;31:909-917. Abstract
Gottschalk AJ, Conaway RC,
Conaway JW. New clues to actin function in chromatin regulation. Nat
Struct Mol Biol. 2008;15:432-433. Abstract
Sardiu ME, Cai Y, Jin J, Swanson
SK, Conaway RC, Conaway JW, Florens L, Washburn MP. Probabilistic
assembly of human protein interaction networks from label-free quantitative
proteomics. Proc Natl Acad Sci U S A. 2008;105:1454-1459. Abstract
Mahrour N, Redwine WB, Florens L, Swanson SK,
Martin-Brown S, Bradford WD, Staehling-Hampton K, Washburn MP, Conaway RC, Conaway JW.
Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1
and Cul5-Rbx2 modules to Elongin BC-based ubiquitin ligases. J Biol Chem.
2008;283:8005-8013. Abstract
Koutelou E, Sato S, Tomomori-Sato C, Florens L, Swanson SK,
Washburn MP, Kokkinaki M, Conaway RC,
Conaway JW, Moschonas NK. Neuralized-like 1 (Neurl1) targeted to the plasma
membrane by N-Myristoylation regulates
the Notch ligand Jagged1. J Biol Chem. 2008;283:3846-3853. Abstract
Cai Y, Jin J, Yao T, Gottschalk AJ, Swanson SK,
Wu S, Shi Y, Washburn MP, Florens L, Conaway
RC, Conaway JW. YY1 functions with INO80 to activate transcription. Nat
Struct Mol Biol. 2007;14:872-874. Abstract
Banks CA, Kong SE, Spahr H, Florens L, Martin-Brown S, Washburn MP, Conaway JW, Mushegian A, Conaway RC. Identification and
Characterization of a Schizosaccharomyces
pombe RNA Polymerase II Elongation
Factor with Similarity to the Metazoan Transcription Factor ELL. J Biol Chem.
2007;282:5761-5769. Abstract
Svejstrup JQ, Conaway RC,
Conaway JW. RNA Polymerase II: A "Nobel" Enzyme Demystified. Mol
Cell. 2006;24:637-642. Abstract
Paoletti AC, Parmely TJ, Tomomori-Sato C, Sato S, Zhu D, Conaway RC, Conaway JW, Florens L,
Washburn MP. Quantitative proteomic analysis of distinct mammalian Mediator
complexes using normalized spectral abundance factors. Proc Natl Acad Sci U
S A. 2006;103:18928-18933. Abstract
Charlet-Berguerand N, Feuerhahn S, Kong SE, Ziserman H, Conaway JW, Conaway R, Egly JM. RNA
polymerase II bypass of oxidative DNA damage is regulated by transcription
elongation factors. EMBO J. 2006;25:5481-5491. Abstract
Yao T, Song L, Xu W, Demartino GN, Florens L, Swanson SK, Washburn
MP, Conaway RC, Conaway JW, Cohen
RE. Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme
by Adrm1. Nat Cell Biol. 2006;8:994-1002.
Abstract
Cai Y, Jin J, Gottschalk AJ, Yao
T, Conaway JW, Conaway RC. Purification
and assay of the human INO80 and SRCAP chromatin remodeling complexes. Methods.
2006;40:312-317. Abstract
Ruhl DD, Jin J, Cai Y, Swanson S, Florens L, Washburn MP, Conaway RC, Conaway JW, Chrivia JC.
Purification of a human SRCAP complex that remodels chromatin by incorporating
the histone variant H2A.Z into nNucleosomes. Biochemistry (Mosc). 2006;45:5671-5677. Abstract
Cai Y, Jin J, Florens L, Swanson
SK, Kusch T, Li B, Workman JL,
Washburn MP, Conaway RC, Conaway JW.
The mammalian YL1 protein is a shared subunit of the TRRAP/TIP60 histone
acetyltransferase and SRCAP complexes. J Biol Chem. 2005. Abstract
Sato S, Tomomori-Sato C, Parmely TJ, Florens L, Zybailov B, Swanson SK,
Banks CA, Jin J, Cai Y, Washburn MP, Conaway
JW, Conaway RC. A set of consensus Mammalian mediator subunits identified
by multidimensional protein identification technology. Mol Cell. 2004;14:685-691.
Abstract
Tomomori-Sato C, Sato S, Parmely TJ, Banks CA, Sorokina I, Florens L, Zybailov
B, Washburn MP, Brower CS, Conaway RC,
Conaway JW. A mammalian mediator subunit that shares properties with
Saccharomyces cerevisiae mediator subunit Cse2. J Biol Chem. 2004.
Abstract.
Cai Y, Jin J, Tomomori-Sato C, Sato S, Sorokina I, Parmely TJ, Conaway RC, Conaway JW. Identification
of new subunits of the multiprotein mammalian TRRAP/TIP60-containing histone
acetyltransferase complex. J Biol Chem. 2003;278:42733-42736. Abstract
Conaway RC, Kong SE, Conaway JW. TFIIS and GreB: two
like-minded transcription elongation factors with sticky fingers. Cell.
2003;114:272-274. Abstract
Dvir A, Conaway JW, Conaway RC.
Assays for investigating the mechanism of promoter escape by RNA polymerase II.
Methods Enzymol. 2003;370:733-740. Abstract
Kong S, Shilatifard A, Conaway RC,
Conaway JW. Preparation and assay of RNA polymerase II elongation factors
elongin and ELL. Methods Enzymol. 2003;371:276-283. Abstract
Kuznetsova AV, Meller J, Schnell PO, Nash JA, Ignacak ML, Sanchez Y, Conaway JW, Conaway RC, Czyzyk-Krzeska
MF. von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA
polymerase II through a proline hydroxylation motif and targets it for
ubiquitination. Proc Natl Acad Sci U S A. 2003;100:2706-2711. Abstract.
Maynard MA, Qi H, Chung J, Lee EH, Kondo Y, Hara S, Conaway RC, Conaway JW, Ohh M. Multiple splice variants of the
human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin
ligase complex. J Biol Chem. 2003;278:11032-11040. Abstract
Sato S, Tomomori-Sato C, Parmely TJ, Florens L, Zybailov B, Swanson SK, Banks
CA, Jin J, Cai Y, Washburn MP, Conaway
JW, Conaway RC. A set of consensus Mammalian mediator subunits identified
by multidimensional protein identification technology. Mol Cell. 2004;14:685-691.
Abstract
Sato S, Tomomori-Sato C, Banks CA, Parmely TJ, Sorokina I, Brower CS, Conaway RC, Conaway JW. A mammalian
homolog of Drosophila melanogaster transcriptional coactivator intersex Is a
subunit of the mammalian mediator complex. J Biol Chem. 2003;278:49671-49674.
Abstract.
Sato S, Tomomori-Sato C, Banks CA, Sorokina I, Parmely TJ, Kong SE, Jin
J, Cai Y, Lane WS, Brower CS, Conaway
RC, Conaway JW. Identification of mammalian Mediator subunits with
similarities to yeast Mediator subunits Srb5, Srb6, Med11, and Rox3. J Biol
Chem. 2003;278:15123-15127. Abstract
Shilatifard A, Conaway RC,
Conaway JW. The RNA polymerase II elongation complex. Annu Rev Biochem.
2003;72:693-715. Abstract
Brower CS, Sato S, Tomomori-Sato C, Kamura T, Pause A, Stearman R,
Klausner RD, Malik S, Lane WS, Sorokina I, Roeder RG, Conaway JW, Conaway RC. Mammalian mediator subunit mMED8 is an
Elongin BC-interacting protein that can assemble with Cul2 and Rbx1 to
reconstitute a ubiquitin ligase. Proc Natl Acad Sci U S A. 2002;99:10353-10358.
Abstract
Conaway JW, Conaway RC. RNA
Polymerases. In: HH Kazazian, and John Wiley & Sons., eds. Wiley
Eencyclopedia of Molecular Medicine. New
York: John Wiley & Sons, Inc.; 2002:2840-2843
2845 v. (xxix, 3699 p.). Abstract
Conaway RC, Brower CS, Conaway JW. Emerging roles of ubiquitin
in transcription regulation. Science. 2002;296:1254-1258. Abstract
Conaway RC, Conaway JW. The von
Hippel-Lindau tumor suppressor complex and regulation of hypoxia-inducible
transcription. Adv Cancer Res. 2002;85:1-12. Abstract
Ivan M, Haberberger T, Gervasi DC, Michelson KS, Gunzler V, Kondo K, Yang H,
Sorokina I, Conaway RC, Conaway JW, Kaelin WG, Jr. Biochemical
purification and pharmacological inhibition of a mammalian prolyl hydroxylase
acting on hypoxia-inducible factor. Proc Natl Acad Sci U S A. 2002;99:13459-13464.
Abstract
Kamura T, Conaway JW, Conaway RC.
Roles of SCF and VHL ubiquitin ligases in regulation of cell growth. Prog
Mol Subcell Biol. 2002;29:1-15. Abstract
Kamura T, Brower CS, Conaway RC, Conaway
JW. A molecular basis for stabilization of the von Hippel-Lindau (VHL)
tumor suppressor protein by components of the VHL ubiquitin ligase. J Biol
Chem. 2002;277:30388-30393. Abstract
Zheng N, Schulman BA, Song L, Miller JJ, Jeffrey PD, Wang P, Chu C,
Koepp DM, Elledge SJ, Pagano M, Conaway
RC, Conaway JW, Harper JW, Pavletich NP. Structure of the Cul1-Rbx1-Skp1-F
boxSkp2 SCF ubiquitin ligase complex. Nature. 2002;416:703-709. Abstract
Querido E, Blanchette P, Yan Q, Kamura T, Morrison M, Boivin D, Kaelin
WG, Conaway RC, Conaway JW, Branton
PE. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a
novel mechanism involving a Cullin-containing complex. Genes Dev. 2001;15:3104-3117.
Abstract
Elmendorf BJ, Shilatifard A, Yan Q, Conaway RC,
Conaway JW. Transcription factors TFIIF, ELL, and Elongin negatively
regulate SII-induced nascent transcript cleavage by non-arrested RNA polymerase
II elongation intermediates. J Biol Chem. 2001;276:23109-23114. Abstract.
Kamura T, Burian D, Yan Q, Schmidt SL, Lane WS, Querido E, Branton PE,
Shilatifard A, Conaway RC, Conaway JW. Muf1, a novel Elongin
BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1
to reconstitute a ubiquitin ligase. J Biol Chem. 2001;276:29748-29753. Abstract.
Kamura T, Sato S, Iwai K, Czyzk-Kryzeska M, Conaway RC, Conaway JW. Activation
of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor
suppressor complex. Proc Natl Acad Sci USA. 2000;97:10430-10435. Abstract.
Kamura T, Conrad MN, Yan Q, Conaway RC, Conaway JW. The Rbx1 subunit of
SCF and VHL E3 ubiquitin ligase activates Rub1 modifications of cullins Cdc53
and Cul2. Genes Dev. 1999;13:2928-2933. Abstract.
Kamura T, Koepp DM, Conrad MN, Skowyra D, Moreland RJ, Iliopoulos O, Lane WS,
Kaelin WG Jr, Elledge S, Harper W, Conaway RC, Conaway JW. Rbx1, a
Component of the VHL Tumor Suppressor Complex and SCF Ubiquitin Ligase. Science.
1999;284:657-661. Abstract.
Skowyra D, Koepp DM, Kamura T, Conrad M, Conaway RC, Conaway JW, Elledge
SJ, Harper JW. Reconstitution of G1 cyclin ubiquitination with complexes
containing SCFGrr1 and Rbx1. Science. 1999;284:662-665. Abstract.
Kamura T, Haque D, Liu L, Kaelin WG, Conaway RC, Conaway JW. The Elongin
BC complex interacts with the SOCS-box motif present in members of the
suppressors of cytokine signalling (SOCS), Ras, WD-40 repeat, and ankyrin
repeat families. Genes Dev. 1998;12:3872-3881. Abstract.
Dvir A, Conaway RC, Conaway JW. A role for TFIIH in controlling the
activity of early RNA polymerase II elongation complexes. Proc Natl Acad Sci
USA.
1997;94:9006-9010. Abstract.
Shilatifard A, Lane WS, Jackson KW, Conaway RC, Conaway JW. An RNA
polymerase II elongation factor encoded by the human ELL gene. Science.
1996;271:1873-1876. Abstract.
Duan DR , Pause A, Burgess WH, Aso T, Chen DYT, Garrett KP, Conaway RC,
Conaway JW, Linehan WM, Klausner RD. Inhibition of transcription elongation
by the von Hippel-Lindau tumor suppressor protein. Science.
1995;269:1402-1406. Abstract.
Aso T, Lane WS, Conaway RC, Conaway JW. Elongin (SIII): A multisubunit
regulator of elongation by RNA polymerase II. Science.
1995;269:1439-1443. Abstract.
Return to Research Team |